135. Cost Effectiveness of Rapid Infusion Time of Ocrelizumab and Can Safely Be Delivered in Saudi Tertiary Hospital

Authors
Category Primary study
JournalMultiple Sclerosis and Related Disorders
Year 2024
This article has no abstract
Epistemonikos ID: bc3edcf997e19b7672f88d857557a31a5accf3ce
First added on: Feb 19, 2025